HEXO Corp. Cash and Cash Equivalents 2011-2026 | HEXO

Annual Cash and Cash Equivalents HEXO Corp.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
83.2 M	67.5 M	184 M	114 M	99 M	38.5 M	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
184 M	38.5 M	97.7 M

Quarterly Cash and Cash Equivalents HEXO Corp.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	67.5 M	-	-	-	184 M	-	-	-	114 M	-	-	-	99 M	-	-	-	38.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
184 M	38.5 M	101 M

Cash and Cash Equivalents of other stocks in the Drug manufacturers industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	5.89 M	-	7.5 %	$ 6.35 M	USA
Aerie Pharmaceuticals AERI	37.2 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	2.56 M	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.08 M	-	0.86 %	$ 117 M	USA
Cumberland Pharmaceuticals CPIX	18 M	$ 4.19	3.2 %	$ 58.9 M	USA
Catalent CTLT	289 M	-	-	$ 11.5 B	USA
Alimera Sciences ALIM	12.1 M	-	-	$ 142 M	USA
Athenex ATNX	30.4 M	-	-23.39 %	$ 1.76 M	USA
DURECT Corporation DRRX	28.4 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	55.3 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	778 M	-	-	$ 28.9 M	Irlanda
Avadel Pharmaceuticals plc AVDL	51.4 M	-	-	$ 2.06 B	France
Evoke Pharma EVOK	4.74 M	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	956 M	-	-0.1 %	$ 2.03 B	Schweden
Bausch Health Companies BHC	947 M	$ 5.58	-0.89 %	$ 2.04 B	Canada
Jupiter Wellness JUPW	2.28 M	-	-	$ 33.6 M	USA
Canopy Growth Corporation CGC	114 M	$ 1.2	1.27 %	$ 129 M	Canada
Harrow Health HROW	72.9 M	$ 41.41	4.31 %	$ 1.52 B	USA
Sonoma Pharmaceuticals SNOA	5.37 M	$ 1.11	-2.63 %	$ 1.38 M	USA
Lannett Company LCI	87.9 M	-	1.15 %	$ 7.11 M	USA
Solid Biosciences SLDB	59.9 M	$ 7.5	-5.3 %	$ 656 M	USA
Tilray TLRY	207 M	$ 6.89	2.07 %	$ 4.26 B	Canada
OrganiGram Holdings OGI	24.6 M	$ 1.44	-0.35 %	$ 402 M	Canada
Organogenesis Holdings ORGO	136 M	$ 2.39	1.7 %	$ 315 M	USA
Evolus EOLS	53.8 M	$ 5.22	-1.51 %	$ 337 M	USA
Sundial Growers SNDL	252 M	$ 1.51	-	$ 3.37 M	Canada
Veru VERU	24.9 M	$ 2.34	0.86 %	$ 316 M	USA
Emergent BioSolutions EBS	112 M	$ 8.03	0.06 %	$ 411 M	USA
Pacira BioSciences PCRX	277 M	$ 25.55	4.24 %	$ 1.18 B	USA
Viatris VTRS	992 M	$ 14.81	1.51 %	$ 17.8 B	USA
Neoleukin Therapeutics NLTX	104 M	-	-	$ 193 M	Canada
ProPhase Labs PRPH	9.11 M	-	-	$ 5.07 M	USA
cbdMD YCBD	2.45 M	$ 0.97	-3.96 %	$ 4.18 M	USA
Radius Health RDUS	112 M	-	-	$ 1.42 B	USA
Assertio Holdings ASRT	10.2 M	$ 18.04	-	$ 116 M	USA
PetIQ PETQ	116 M	-	1.64 %	$ 400 M	USA
Relmada Therapeutics RLMD	3.5 M	$ 7.03	-2.5 %	$ 278 M	USA
Recro Pharma REPH	8.1 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	73.7 M	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	21.3 M	$ 1.0	-1.96 %	$ 49.9 M	USA
PLx Pharma PLXP	69.4 M	-	-27.8 %	$ 2.56 M	USA
Aurora Cannabis ACB	138 M	$ 3.51	3.54 %	$ 86.3 M	Canada
Zomedica Corp. ZOM	9.02 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	50.6 M	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	10.7 M	$ 0.85	-3.09 %	$ 30.6 M	USA
Tricida TCDA	21.1 M	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	345 K	$ 0.59	-6.53 %	$ 2.53 M	China
TherapeuticsMD TXMD	7.48 M	$ 2.07	-5.48 %	$ 23.9 M	USA